HIGH-GRADE B-CELL LYMPHOMA (HGBL)

Clinical trials for HIGH-GRADE B-CELL LYMPHOMA (HGBL) explained in plain language.

Never miss a new study

Get alerted when new HIGH-GRADE B-CELL LYMPHOMA (HGBL) trials appear

Sign up with your email to follow new studies for HIGH-GRADE B-CELL LYMPHOMA (HGBL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1

New CAR-T therapy trial offers hope for patients with aggressive lymphoma

Disease control Recruiting now

This study is testing a new CAR-T cell therapy called TC011 for adults with aggressive B-cell lymphoma that has come back or hasn't responded to at least two prior treatments. The main goals are to find a safe dose and see if the therapy can shrink or eliminate tumors. It is for …

Matched conditions: HIGH-GRADE B-CELL LYMPHOMA (HGBL)

Phase: PHASE1, PHASE2 • Sponsor: TICAROS Co., Ltd. • Aim: Disease control

Last updated Mar 25, 2026 14:08 UTC

HIGH-GRADE B-CELL LYMPHOMA (HGBL)

Get alerted when new HIGH-GRADE B-CELL LYMPHOMA (HGBL) trials appear

New CAR-T therapy trial offers hope for patients with aggressive lymphoma